OUR

TECHNOLOGIES

GET TO KNOW

THE TECHNOLOGICAL TOOLS WE USE

We contribute to the improvement of the quality of life and psychosocial interactions, cognitive rehabilitation, illness awareness, adherence to treatment and avoidance of relapse of our patients. 

 

Grupo Punto de Partida has a commitment with technology and is continuously searching for the most advanced tools throughout the world for the treatment of our patients. 

BRAIN IMAGERY

CEREBRAL

 
Brain imagery consists of diagnostic tests that use magnetic fields and radiofrequency waves to obtain images of the brain.  
They allow the identification of neurologic issues and improve treatment efficacy. 

TESTS

PHARMACOGENOMIC 

PHARMACOGENOMIC

TESTS

At Grupo Punto de Partida we use this innovative, cutting-edge tool that involves using an individual’s genetic material to guide the decisions made regarding prevention, diagnosis, treatment and specific dosing, to ensure an appropriate treatment and pharmacological regimen for a specific patient. 
 
Pharmacogenomics is a branch of pharmacology that uses genetic information (DNA) and data from the amino acid sequence in proteins to correlate genetic variations with the response to medications. 
At Grupo Punto de Partida we use this analysis to answer the following question: 
Will the patient have a positive response to a specific medication (the expected therapeutic response) or a negative one (no therapeutic response), and will they have a side effect to it?
 
 

TRANSCRANIAL MAGNETIC STIMULATION 

TRANSCRANIAL MAGNETIC STIMULATION

This is a non-invasive process that uses magnetic fields to stimulate nerve cells to modify their activity, both within the neurons themselves, as well as in the connections with other neurons.  The treatment involves the emission of repeated magnetic pulses, thus the name repeated transcranial magnetic stimulation or rTMS. 

Magnetic brain simulation is often used when treatments for mental disorders are ineffective, or to achieve rehabilitation of learning through neuromodulation. 

 

In this therapy, the magnetic impulses used are painless and may stimulate nervous cells by exciting or inhibiting them. 

 

TMS is a non-invasive form of brain stimulation used to treat depression and does not require anesthesia or sedation.  

 

In general, rTMS is considered safe and well tolerated. It is not recommended for people with a history of epilepsy and in those with metallic devices or implants.

SUBCUTANEOUS IMPLANTS 

SUBCUTANEOUS IMPLANTS 

THE LATEST TREATMENT FOR ADDICITON!

Implants have high concentrations of medication such as naltrexone that are liberated gradually in the body. Thus, it is no longer necessary for the patient to remember to take a daily tablet, so family members no longer have to worry if the patient swallowed the tablet or spit it out.  
Patients are advised to use the protection of implants for at least 12 months before being discharged. Implants can be inserted an unlimited number of times as physical dependence to naltrexone cannot be developed.
 
 
 
The use of naltrexone is a pharmacologic method indicated for patients with dependence to alcohol or psychostimulants, as well as gaming addiction. It blocks neuron receptors and so avoids these from producing an effect. Thus, the person will feel no satisfaction or well-being when consuming the drug or gambling; on the contrary this will cause very unpleasant and even dangerous reactions in the body. 

 

Implants support psychosocial treatment, increasing adherence to treatment and reducing relapse after treatment.

NEUROPSYCHOLOGY 

NEUROPSICOLOGÍA


This includes all activities aimed at improving and reestablishing function at the highest level possible and restoring cognitive performance in general or processes such as:
attention, memory, language, executive functions, calculations, among others, in patients with some degree of damage to the central nervous system or with a physical or psychological neuropsychiatric disorder. 

Neuropsychological rehabilitation promotes a decrease in behavioral performance and learning.  

 

Activity training or stimulation creates new functional pathways in a damaged brain. New experiences and learning modify neurons and allow the appearance of new synapses or connections in the brain. This brain plasticity promotes functional restructuring not only in damaged areas, but also in other unaffected parts, in such a way that the new connections can partially take over the functions that have been damaged.

KETAMINE / ESKETAMINE

KETAMINA / ESKETAMINA

Scientific evidence shows that in patients with no symptom relief after two cycles with antidepressants, nearly half can significantly improve with a single dose of ketamine. 
Ketamine is one of the most effective treatments for major or chronic depression. A major difference of ketamine with respect to other treatments is the speed at which it produces its antidepressant effect. 
While conventional medications take from two to six weeks to have an effect, a metanalytical study showed that 36% of patients improved significantly before 24 hours, 41% at 24 hours and 48% between 2 and 7 days after a single infusion of ketamine. 
 

 

This is a key factor, especially in people at considerable risk for suicide. In such cases, the speed at which suicidal thoughts are lessened can avoid fatal events. 
Patients are monitored and under medical supervision for 40 to 60 minutes during ketamine administration, and if the patient wishes, the treatment can be interrupted at any time. A period of rest may be required, until the person is in perfect condition to leave the clinic. The treatment is always ambulatory, and it rarely takes more than an hour and a half. 

ELECTROENCEPHALOGRAPHY

Performed with innovative equipment and interpreted by highly qualified personnel.

NEUROMODULATION 

This neuroscientific discipline includes non-invasive brain stimulation techniques that allow long-term modification of brain activity. 
It is mainly used to treat mood disorders, such as depression resistant to pharmacologic treatment, and comorbidities of other disorders.